Insulin Therapy, Insulin Resistance and Vascular Dysfunction

Author(s): M.C. Vázquez , L. Sobrevia .

Journal Name: Current Vascular Pharmacology

Volume 17 , Issue 5 , 2019

Become EABM
Become Reviewer

[1]
Villalobos-Labra R, Subiabre M, Toledo F, Pardo F, Sobrevia L. Endoplasmic reticulum stress and development of insulin resistance in adipose, skeletal, liver, and foetoplacental tissue in diabesity. Mol Aspects Med 2019; 66: 49-61.
[2]
Zhou Q, Melton DA. Pancreas regeneration. Nature 2018; 557: 351-8.
[3]
World Health Organization (WHO) 2018. Obesity and overweight. Fact sheet 311. World Health Organization, Geneva, Switzerland. Available at (http://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight). Accessed on August 20, 2018.
[4]
Kalra S. Diabesity J Pak Med Assoc 2013; 63: 532-4.
[5]
Ziv E, Shafir E. Psammomys obesus (Sand Rat): Nutritionally induced NIDDM-like syndrome on a thrifty gene background. In: Shafir E. Ed.Lessons from animal diabetes. Smith-Gordon: London 1995; Vol. 5: pp. 285-300.
[6]
Wang Q, Huang R, Yu B, et al. Higher fetal insulin resistance in Chinese pregnant women with gestational diabetes mellitus and correlation with maternal insulin resistance. PLoS One 2013; 8e59845
[7]
Subiabre M, Villalobos-Labra R, Silva L, Fuentes G, Toledo F, Sobrevia L. Role of insulin, adenosine, and adipokine receptors in the foetoplacental vascular dysfunction in gestational diabetes mellitus. Biochim Biophys Acta Mol Basis Dis 2019; 925: 30513-1.
[8]
Laakso M, Kuusisto J. Insulin resistance and hyperglycaemia in cardiovascular disease development. Nat Rev Endocrinol 2014; 10: 293-302.
[9]
Baranowska-Bik A, Bik W. Vascular dysfunction and insulin resistance in aging. Curr Vasc Pharmacol 2019; 17: 465-75.
[10]
Carracedo J, Alique M, Ramírez-Carracedo R, Bodega G, Ramírez R. Endothelial extracellular vesicles produced by senescent cells: pathophysiological role in the cardiovascular disease associated with all types of diabetes mellitus. Curr Vasc Pharmacol 2019; 17: 447-54.
[11]
Sáez T, Toledo F, Sobrevia L. Extracellular vesicles and insulin resistance: A potential interaction in vascular dysfunction. Curr Vasc Pharmacol 2019; 17: 491-7.
[12]
Wiggenhauser LM, Kroll J. Vascular damage in obesity and diabetes: Highlighting links between endothelial dysfunction and metabolic disease in zebrafish and man. Curr Vasc Pharmacol 2019; 17: 476-90.
[13]
Krizhanovskii C, Franco-Cereceda A. Diabetes, incretin therapy and thoracic aortic aneurysm – what does the evidence show? Curr Vasc Pharmacol 2019; 17: 432-9.
[14]
Mate A, Blanca AJ, Salsoso R, et al. Insulin therapy in pregnancy hypertensive diseases and its effect on the offspring and mother later in life. Curr Vasc Pharmacol 2019; 17: 455-640.
[15]
Ramírez MA, Beltrán AR, Araya JE, et al. Involvement of intracellular pH in vascular insulin resistance. Curr Vasc Pharmacol 2019; 17: 440-6.
[16]
Pardo F, Sobrevia L. Adenosine receptors in gestational diabetes mellitus and maternal obesity in pregnancy. In: Andrea B, Pier V, Katia G, Stefannia M, Vicenzi F, Eds. The adenosine receptors, the receptors 34 Humana Press: Springer Nature Switzerland. Cham, Switzerland 2018; pp. 529-42.
[17]
Cabalín C, Villalobos-Labra R, Toledo F, Sobrevia L. Involvement of A2B adenosine receptors as anti-inflammatory in gestational diabesity. Mol Aspects Med 2019; 66: 31-9.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 17
ISSUE: 5
Year: 2019
Page: [429 - 431]
Pages: 3
DOI: 10.2174/157016111705190703103110

Article Metrics

PDF: 9
HTML: 3